Diagnostic Imaging
-
RadNet Announces Record Q2 Results & Raised 2025 Guidance
RadNet (RDNT) reported record Q2 2025 results, with revenue up 8.4% to $498.2M and Adjusted EBITDA increasing 12.3% to $81.2M. Digital Health segment revenue rose 30.9% to $20.7M. Advanced imaging volumes grew strongly: MRI +9.0%, CT +8.1%, PET/CT +22.4%. Adjusted EPS nearly doubled to $0.31. RadNet raised its 2025 revenue guidance to $1.85-1.90 billion and Adjusted EBITDA to $271-279 million. The company holds $833.2M cash and a low 0.96x leverage ratio.
